BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our Industry eNewsletter FREE email:    
 Investor News
Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings
Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions 
Start-Ups
IPO News
IPO
 


Clinical - Phase I
XBiotech USA, Inc. Announces Phase I/II Study Results In Lancet 4/17/2014 12:26:11 PM    More...
One Of A Kind Trial To Test 14 AstraZeneca PLC (AZN), Pfizer Inc. (PFE) Drugs At The Same Time 4/17/2014 7:04:59 AM    More...
Dicerna Pharmaceuticals (DRNA) Initiates Phase 1 Study Of DCR-MYC In Patients With Solid Tumors And Hematological Malignancies 4/17/2014 9:46:01 AM    More...
StemCells Inc. (STEM) Completes Enrollment In Spinal Cord Injury Trial 4/17/2014 9:41:19 AM    More...
Agios Pharmaceuticals (AGIO) Initiates Phase 1 Study Of AG-348, A First-in-class PKR Activator, For Pyruvate Kinase Deficiency 4/17/2014 9:30:24 AM    More...
Galectin Therapeutics Announces First Patient Dosed In Second Cohort Of Phase 1 Trial Of GR-MD-02 For NASH With Advanced Fibrosis 4/17/2014 9:27:45 AM    More...
Bay Area's Igenica, Inc. Follows Genentech (RHHBY) Into Antibody-Linked Cancer Drugs 4/14/2014 7:10:07 AM    More...
Cleveland Biolabs Inc. (CBLI) Announces The Successful Completion Of A Phase 1 Study Of CBL0102 4/16/2014 10:19:02 AM    More...
Karyopharm Therapeutics (KPTI) Announces Initiation Of A Phase 1 Study Of Decitabine (Dacogen®) And Selinexor (KPT-330) In Acute Myeloid Leukemia (AML) 4/16/2014 9:32:40 AM    More...
Critical Pharmaceuticals Limited, The University of Nottingham And Nottingham University Hospitals NHS Trust Starts First Phase I Clinical Trial On A Nano-Enabled Intranasal Teriparatide For The Treatment Of Osteoporosis 4/15/2014 11:16:35 AM    More...
ProTrials Research, Inc. Completes Significant Phase III Clinical Trial For New Ophthalmic Disease Treatment 4/14/2014 2:39:15 PM    More...
Long-Term Outcomes From Cytori Cell Therapy Trial For Heart Failure Published In American Heart Journal 4/14/2014 9:38:09 AM    More...
Vectura Group plc (VEC.L): FAVOLIR Regulatory Update 4/11/2014 9:54:22 AM    More...
Precision Biologics’ NEO-102 Continues To Show Encouraging Results In Pancreatic And Colorectal Cancer Patients 4/11/2014 8:12:50 AM    More...
Whoa. Agios Pharmaceuticals (AGIO)'s Experimental Cancer Drug Makes Cancer Undetectable In Three Patients 4/7/2014 7:31:23 AM    More...
1234567
 

//-->